WEX C-Suite Sold $6.8M as Stock Ran From $143 to $191
Five WEX Inc. executives sold a combined $6.83 million in stock between July 6 and September 1, 2026 — with zero purchases — as the stock climbed from $143 to above $191 following the company's strong
WEX C-Suite Sold $6.8M as Stock Ran From $143 to $191
NEW YORK, September 6 —
WEX Inc. (WEX) delivered its strongest quarterly earnings beat in a four-quarter winning streak, then watched five of its most senior executives sell $6.83 million in stock at successively higher prices with zero offsetting purchases as the rally ran. The stock now sits at $193.91, above the $192.40 average analyst price target, with the insiders already out.
- Q2 EPS of $5.35 beat the $5.07 consensus by 5.5%, the widest positive surprise in four consecutive quarterly beats.
- CEO, both COOs, CRO, and CAO sold $6.83M between July 6 and September 1, 2026; no purchases recorded.
- WEX trades at $193.91, above the $192.40 analyst consensus target; forward P/E is 9.1x with 10.4% short interest.
Every Price Got a Seller
The insider selling unfolded as a staircase, each wave at a higher price than the last. COO Robert Deshaies opened the sequence on July 6 at $143, $149. Chief Risk Officer Ann Drew and Chief Accounting Officer Jennifer Kimball transacted on July 27 at $176, $177. COO Carlos Carriedo sold on August 4 at $186. Melissa Smith closed the sequence on September 1, exercising options struck at $99, $105 before selling the resulting shares into the open market at $186, $191. Routine compensation monetization looks different when five separate officers chose the same three-month window with no purchases at any price.
A Software-Grade Margin on a Payments Base
WEX runs fleet card and AP automation payments for commercial operators, government fleets, and travel buyers (through its Mobility and Corporate Payments segments) alongside a SaaS Benefits platform covering HSA and COBRA accounts. That software-payments blend generates 73.2% gross margins on $2.79 billion in trailing revenue growing 14.2%. Four consecutive quarterly EPS beats, with the most recent the widest of the streak, argue that analyst consensus models trail the actual trajectory, a case worth stress-testing with a DCF calculator before the next earnings quarter.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| WEX | $6.6B | 9.1x | +12.4% |
| GMED | $10.5B | 14.5x | +31.5% |
| BAND | $1.4B | 22.7x | +178.8% |
| EEFT | $2.8B | 6.2x | -18.4% |
| PCTY | $8.4B | 15.7x | -12.0% |
| PEGA | $6.1B | 14.1x | -35.0% |
One More Beat or One Miss Settles It
Smith's exercise-and-sell converted options struck at $99, $105 into proceeds at $186, $191, a rational liquidation of equity compensation at a price that had already cleared the analyst target. The forward multiple is modest for a software-inflected payments platform, but 10.4% short interest signals a significant contingent betting against that case. Whether the next quarter extends the four-beat streak or breaks it resolves the central question: another expanding EPS beat would force analyst target revisions upward, while a miss confirms the insiders read the ceiling correctly. Run the free WEX Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Five WEX Inc. executives sold a combined $6.83 million in stock between July 6 and September 1, 2026 — with zero purchases — as the stock climbed from $143 to above $191 following the company's strongest quarterly earnings beat in a four-quarter winning streak. The stock now sits at $193.91, above the $192.40 analyst consensus price target, as insiders exit at the top of the rally.
Sources & Filings